Corlieve Therapeutics SAS

https://www.corlieve.com

Corlieve Therapeutics is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. The lead project is targeting aberrantly expressed kainate receptors in the hippocampus of patients with refractory TLE using a gene therapy approach. Corlieve was founded by Kurma Partners 4Q2019 on the basis of a partnership with REGENXBIO Inc., SATT Aquitaine Science Transfert, and Inserm Transfert. Corlieve is supported by its investors and partners Kurma Partners, Eurazeo, Pureos Bioventures, SATT Aquitaine Science Transfert, Inserm Transfert, Inserm CNRS, and REGENXBIO. *

	Start	2019-11-01 established
	Industry	gene therapy
	Person	Porter, Richard (Corlieve 201911– CEO + Co-Founder before Therachon + Roche + Shire + Vernalis + Astra)
	Person 2	Malier, Vanessa (Kurma 201412 Partner)

	Region	Paris
	Country	France
	Street	59 rue de Ponthieu
	City	75008 Paris
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Uniqure N.V.. (6/22/21). "Press Release: Uniqure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE)". Lexington, MA, Amsterdam & Paris.

		Record changed: 2024-03-30

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Corlieve Therapeutics SAS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)